Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy

American Journal of Surgical Pathology

Volumn 23, Issue 11, 1999, Pages 1340-1348

  Goldstein, Neal S ^a   Kestin, Larry ^a   Vicini, Frank ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Cancerization of lobules; Intraductal carcinoma; Local excision; Margins; Pathology; Reexcision

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION;

EID: 0032750715     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199911000-00004     Document Type: Article

References (46)

1. Bearhrs OH, Henson DR, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer: breast. Manual for staging of cancer. Philadelphia: JB Lippincott, 1992:149-54.
2. Andersen JA, Nielsen M, Blichert-Toft M. The growth pattern of in situ carcinoma in the female breast. Acta Oncol 1988;27:739-43.
3. Azzopardi JG. Underdiagnosis of malignancy. Problems in breast pathology. In: Bennington JL, ed. Major problems in pathology series. London: WB Saunders, 1979:192-39
4. Bornstein BA, Recht A, Connolly J, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991;67:7-13.
5. Boyages J, Recht A, Connolly J, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990;19:29-41.
6. Cheng L, Al-Kaisi K, Gordon NH, Liu AY, Gebrail F, Shenk RR. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst 1997;89:1356-9.
7. Chinyama CN, Davies JD, Rayter Z, Farndon JR. Factors affecting surgical margin clearance in screen-detected breast cancer and the effect of cavity biopsies on residual disease. Eur J Surg Oncol 1997;23:123-7.
8. Faverly D, Burgers L, Bull P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-8.
9. Faverly D, Holland R, Burgers L. An original stereomicroscopic analysis of the mammary glandular tree. Virchows Archiv A Pathol Anat 1992;421:115-9.
10. Fechner RE. Ductal carcinoma involving the lobule of the breast. A source of confusion with lobular carcinoma in situ. Cancer 1971;28:274-81.
11. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 1994;18:63-9.
12. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
13. Fisher ER. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. Ca Cancer J Clin 1996;47:52-64.
14. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
15. Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991;47:139-47.
16. Fisher ER, Sass R, Fisher B, Wickerham DL, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6) I. Intraductal carcinoma (DCIS). Cancer 1986;57:197-207.
17. Fourquet A, Zafrani B, Campana F, Clough KB. Institut Curie experience. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997:391-7.
18. Fowble BL, Solin LJ, Goodman RL. Results of conservative surgery and radiation for intraductal noninvasive breast cancer. Am J Clin Oncol 1987;10:110-1.
19. Goldstein NS, Lacerna MD, Vicini FA. Cancerization of lobules and atypical ductal hyperplasia adjacent to duct carcinoma in situ of the breast: significance for breast conserving therapy. Am J Clin Pathol 1998;110:357-67.
20. Goldstein NS, Murphy TM. Intraductal carcinoma associated with invasive carcinoma of the breast: a comparison of the two lesions with implications for intraductal carcinoma classification systems. Am J Clin Pathol 1996;106:312-8
21. Haffty B, Peschel RE, Papadopoulos D, Pathare P. Radiation therapy for ductal carcinoma in situ of the breast. Conn Med 1990; 54:482-4.
22. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-92.
23. Holland R, Hendriks JH, Verbeek AL, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335:519-22.
24. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991;21:289-92.
25. Ohtake T, Abe R, Kimijima I, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conserving surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995;76:32-45.
26. Owings DV, Hann L, Schnitt SJ. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study. Am J Surg Pathol 1990;14:578-83.
27. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987.
28. Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 1990;66:1326-35.
29. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis on mammary atypical ductal hyperplasia. Hum Pathol 1992;23:1095-7.
30. Ray GR, Adelson J, Hayhurst E, et al. Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1993;28:105-11.
31. Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol 1985;3:1339-43.
32. Schnitt SJ, Wang HH. Histologic sampling of grossly benign breast biopsies: how much is enough? Am J Surg Pathol 1989;13:505-12.
33. Silverstein MJ. Predicting residual disease and local recurrence in patients with ductal carcinoma in situ. J Natl Cancer Inst 1997; 89:1330-1.
34. Silverstein MJ. Prognostic factors that predict recurrence of DCIS. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997:271-84.
35. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A:1425-7.
36. Silverstein MJ, Cohlan BF, Gierson ED, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992;28: 630-4.
37. Silverstein MJ, Gierson ED, Colburn WJ, et al. Can intraductal breast carcinoma be excised completely by local excision?: clinical and pathologic predictors. Cancer 1994;73:2985-9.
38. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 1990;66:102-8.
39. Solin LJ, Fowble BL, Schultz DJ, Yen IT, Kowalyshyn MJ, Goodman RL. Definitive irradiation for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1990;19:843-50.
40. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14:754-63.
41. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast conserving surgery and definitive irradiation for intraductal carcinoma (duct carcinoma in situ) of the breast. Cancer 1991;68:2337-44.
42. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with beast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment. Cancer 1993;71:2532-42.
43. Stotter AT, McNeese M, Oswald MJ, Ames FC, Romsdahl MM. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys 1990; 18:283-7.
44. Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 1997;185:268-73.
45. Wobbes TH, Tinnemans JGM, van der Sluis RF. Residual tumor after biopsy for non-palpable ductal carcinoma in situ of the breast. Br J Surg 1989;76:185-6.
46. Zafrani B, Fourquet A, Vilcoq JR, Legal M, Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer 1986;57:1299-301.